| D06597 | |
| D number | D06597 |
| Classification | Drug |
| Name | Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
| Component | - |
| Formula | C23H22F7N4O6P. (C7H17NO5)2 |
| Exact mass | 1004.3379 |
| Mol weight | 1004.8337 |
| Structural formula |  |
| Sequence | - |
| Sequence type | - |
| Source | - |
| Upper DGroup | Cyp inhibitor DG01915 CYP3A5 inhibitor |
| Remark | Therapeutic category: 2391 Chemical group: DG02200 |
| Activity | - |
| Disease | - |
| Comment | Active form of prodrug: Aprepitant [DR:D02968] |
| Target | TACR1 (NK1R) [HSA:6869] [KO:K04222] |
| Metabolism | Enzyme: CYP3A4 [HSA:1576] |
| Interaction | CYP inhibition: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577], CYP3A7 [HSA:1551] CYP induction: CYP2C9 [HSA:1559] |
| Other DBs | CAS: 265121-04-8 PubChem: 47208248 ChEBI: 64311 ChEMBL: CHEMBL1201782 LigandBox: D06597 |
| KCF data | - |